1. All Products
  2. D - Drugs
  3. ETHAMBUTOL hydr.(E) eq. 50mg base,disp and break tab.blister
Public Pricelist

ETHAMBUTOL hydr.(E) eq. 50mg base,disp and break tab.blister

https://medicalguidelines.msf.org/en/node/401
https://msf.oodin.sh/cat/product/86702
STD DORAETHA5TD1

Valid Article

Article is intended to be used with children (<12 years) ONLY.
6.2.5 - Antituberculosis medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J04AK02
Anatomical Therapeutic Chemical Classification according to WHOCC
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
https://msf.oodin.sh/web/image/product.template/577672/image_1920?unique=dad6aa6

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

ETHAMBUTOL hydrochloride (E)

Therapeutic Action

Antituberculosis bacteriostatic

Indications

Drug-Resistant tuberculosis (DR-TB), in combination with other TB medicines

Drug-Sensitive tuberculosis (DS-TB)

Instructions for use

The 50 and 100 mg dispersible tablets are intended for paediatric use. To be dispersed in 10 ml of water.

The dispersible tablet should replace the normal 100 mg tablet (second choice).

Blister packaging is the packaging of choice for antituberculosis medicines, due to the instability of some of them when exposed to high temperatures and humidity.

Bulk packaging (hospital packs) should only be used in special circumstances or when the blister presentation is unexpectedly unavailable.

The quantity to be ordered is calculated per tablet, not per blister.

When ethambutol is used in association with other TB medicines, fixed-dose combinations (FDC) are available:

  • E 275mg / H 75mg / Z 400mg / R 150mg, tab., blister
  • E 275mg / H 75mg / R 150mg, tab., blister

Precautions for Use

Do not administer to patients with severe renal impairment or pre-existing optic neuritis (e.g., diabetic retinopathy).

Storage

Below 25ºC ‐ Protect from sunlight ‐ Protect from humidity